不良妊娠结局后心血管疾病风险干预措施综述
本综述检索2000至2021年文献,总结针对有不良妊娠结局(APOs)史女性的产后干预策略。干预分为过渡诊所、生活方式干预、药物治疗和患者及临床医生教育四类;观察性研究提示过渡诊所可识别高危女性,生活方式干预和二甲双胍可能降低妊娠期糖尿病(GD)后2型糖尿病风险,但其他APOs后特异性药物治疗证据缺乏。指南支持用APOs史优化心血管疾病(CVD)风险评估并指导他汀处方,但患者和临床医生认知水平低。
要点
- 过渡诊所可识别CVD高危女性并辅助过渡至长期初级保健。
- 生活方式干预和二甲双胍可能降低GD后2型糖尿病风险。
- 指南支持用APOs史优化CVD风险评估并指导他汀一级预防。
核心结论
- 过渡诊所、生活方式干预、靶向药物治疗及医患教育是改善APOs女性产后心血管代谢健康的有前景策略,但需进一步研究严格评估。
研究设计与样本
- 检索PubMed和Ovid从2000年1月1日至2021年4月30日发表的英文随机临床试验、队列研究、描述性研究和指南。
主要发现
- 观察性研究提示产后过渡诊所可识别CVD风险升高的女性并可能辅助过渡至长期初级保健。
- 增加体力活动和改善饮食质量的生活方式干预可能帮助降低既往GD女性2型糖尿病发病率,其他APOs女性所知较少。
- 盐酸二甲双胍可能预防既往GD女性2型糖尿病发展,其他APOs后特异性药物治疗证据缺乏。
- 研究提示患者和临床医生对APOs与CVD关联的认知水平低。
关键数值与推荐
- 心血管指南支持使用APOs史优化CVD风险评估并指导计算10年CVD风险中等女性的他汀一级预防处方。
临床怎么用
- 对有APOs史女性应考虑使用过渡诊所识别CVD高危并辅助过渡至初级保健。
- 对既往GD女性可考虑生活方式干预或二甲双胍以预防2型糖尿病。
- 对计算10年CVD风险中等女性,应结合APOs史优化风险评估并指导他汀一级预防。
- 应加强患者和临床医生对APOs与CVD关联的认知教育。
局限性
- 其他APOs后特异性药物治疗证据缺乏。
- 生活方式干预对除GD外其他APOs女性的获益所知较少。
- 需进一步研究开发并严格评估这些干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: A growing body of evidence suggests that adverse pregnancy outcomes (APOs), including hypertensive disorders of pregnancy, gestational diabetes (GD), preterm birth, and intrauterine growth restriction, are associated with increased risk of cardiometabolic disease and cardiovascular disease (CVD) later in life. Adverse pregnancy outcomes may therefore represent an opportunity to intervene to prevent or delay onset of CVD. The objective of this review was to summarize the current evidence for targeted postpartum interventions and strategies to reduce CVD risk in women with a history of APOs. OBSERVATIONS: A search of PubMed and Ovid for English-language randomized clinical trials, cohort studies, descriptive studies, and guidelines published from January 1, 2000, to April 30, 2021, was performed. Four broad categories of interventions were identified: transitional clinics, lifestyle interventions, pharmacotherapy, and patient and clinician education. Observational studies suggest that postpartum transitional clinics identify women who are at elevated risk for CVD and may aid in the transition to longitudinal primary care. Lifestyle interventions to increase physical activity and improve diet quality may help reduce the incidence of type 2 diabetes in women with prior GD; less is known about women with other prior APOs. Metformin hydrochloride may prevent development of type 2 diabetes in women with prior GD. Evidence is lacking in regard to specific pharmacotherapies after other APOs. Cardiovascular guidelines endorse using a history of APOs to refine CVD risk assessment and guide statin prescription for primary prevention in women with intermediate calculated 10-year CVD risk. Research suggests a low level of awareness of the link between APOs and CVD among both patients and clinicians. CONCLUSIONS AND RELEVANCE: These findings suggest that transitional clinics, lifestyle intervention, targeted pharmacotherapy, and clinician and patient education represent promising strategies for improving postpartum maternal cardiometabolic health in women with APOs; further research is needed to develop and rigorously evaluate these interventions. Future efforts should focus on strategies to increase maternal postpartum follow-up, improve accessibility to interventions across diverse racial and cultural groups, expand awareness of sex-specific CVD risk factors, and define evidence-based precision prevention strategies for this high-risk population.
引用
- Jowell AR, Sarma AA, Gulati M, et al. Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review. JAMA Cardiol. 2022. PMID: 34705020. doi:10.1001/jamacardio.2021.4391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。